Skip to main navigation Skip to search Skip to main content

Cost effectiveness of pharmacogenetic screening prior to initiation of carbamazepine treatment for epilepsy

    • University of Liverpool
    • Walton Centre for Neurology and Neurosurgery Foundation Trust, Liverpool

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)A624-A624
    JournalValue in Health
    Volume16
    Issue number7
    DOIs
    Publication statusPublished - Nov 2013

    Cite this